Comparison of Efficacy and Safety between Long-Acting Injectable Antipsychotic Monotherapy and Combination of Long-Acting Injectable and Oral Antipsychotics in Patients with Schizophrenia

Table 2

Hospitalization and all-cause discontinuation between LAI antipsychotic monotherapy and combination of LAI and oral antipsychotic groups.

Outcomes	LAI antipsychotic monotherapy group ()	Combination of LAI and oral antipsychotic group ()	OR (95% CI)	value
Hospitalization	3 (12.0)	9 (14.8)	0.79 (0.20, 3.19)	1.00
All-cause discontinuation	1 (4.0)	5 (8.2)	0.47 (0.05, 4.21)	0.67
Lack of efficacy	0 (0.0)	1 (1.6)
Clinician decision	1 (4.0)	1 (1.6)
Intolerable of ADR	0 (0.0)	1 (1.6)
Patient decision	0 (0.0)	2 (3.3)